SE382211B - Forfarande for framstellning av nya beta-aryl-2-aminoalkoxi-styrener - Google Patents

Forfarande for framstellning av nya beta-aryl-2-aminoalkoxi-styrener

Info

Publication number
SE382211B
SE382211B SE7010773A SE1077370A SE382211B SE 382211 B SE382211 B SE 382211B SE 7010773 A SE7010773 A SE 7010773A SE 1077370 A SE1077370 A SE 1077370A SE 382211 B SE382211 B SE 382211B
Authority
SE
Sweden
Prior art keywords
aminoalcoxy
styrenes
aryl
procedure
manufacture
Prior art date
Application number
SE7010773A
Other languages
English (en)
Swedish (sv)
Inventor
E Muller
R Maier
W Diederen
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SE382211B publication Critical patent/SE382211B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
    • C07C39/20—Hydroxy-styrenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Illuminated Signs And Luminous Advertising (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
SE7010773A 1969-08-05 1970-08-05 Forfarande for framstellning av nya beta-aryl-2-aminoalkoxi-styrener SE382211B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1939809A DE1939809B2 (de) 1969-08-05 1969-08-05 ß-Aryl-2-aminoalkoxy-styrole und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
SE382211B true SE382211B (sv) 1976-01-19

Family

ID=5741970

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7010773A SE382211B (sv) 1969-08-05 1970-08-05 Forfarande for framstellning av nya beta-aryl-2-aminoalkoxi-styrener

Country Status (25)

Country Link
JP (6) JPS4941433B1 (de)
KR (1) KR780000113B1 (de)
AT (5) AT301565B (de)
BE (1) BE754405A (de)
BG (6) BG17951A3 (de)
CH (6) CH548367A (de)
CS (6) CS170533B2 (de)
DE (1) DE1939809B2 (de)
DK (1) DK139717B (de)
ES (6) ES382428A1 (de)
FI (1) FI54912C (de)
FR (1) FR2068463B1 (de)
GB (1) GB1307436A (de)
HU (1) HU163185B (de)
IE (1) IE34634B1 (de)
IL (1) IL35047A (de)
NL (1) NL7011590A (de)
NO (1) NO135243C (de)
PH (1) PH9520A (de)
PL (2) PL93130B1 (de)
RO (5) RO57794A (de)
SE (1) SE382211B (de)
SU (5) SU439965A3 (de)
YU (2) YU198170A (de)
ZA (1) ZA705411B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS50139537A (de) * 1974-04-25 1975-11-07
US4220603A (en) * 1977-10-07 1980-09-02 Mitsubishi Chemical Industries, Limited Pharmaceutically active (omega-aminoalkoxy)bibenzyls
JPS6045632B2 (ja) * 1978-03-09 1985-10-11 三菱化学株式会社 ω−アミノアルコキシスチルベン類及びその酸付加塩
DE2818765A1 (de) 1978-04-28 1979-11-08 Basf Ag Aminoderivate des 2-methyl-5-(2-hydroxystyrol)-1,3,4-thiadiazols
DE2818998A1 (de) * 1978-04-29 1979-11-15 Basf Ag 3-alkyl-5-(2-hydroxy-styryl)-isoxazole und verfahren zu ihrer herstellung
DE2818999A1 (de) * 1978-04-29 1979-11-15 Basf Ag Aminoderivate von 3-alkyl-5-(2- hydroxystyryl)-isoxazolen
JPS5629548A (en) * 1979-08-16 1981-03-24 Mitsubishi Chem Ind Ltd Omega-aminoalkoxystilbenes and their acid addition salts
DE2943406A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Aminoderivate des 2-methyl-5-(2-hydroxystyryl)-1,3,4-thiadiazols
DE2943405A1 (de) 1979-10-26 1981-05-07 Basf Ag, 6700 Ludwigshafen Neue aminoderivate des 5-(2-hydroxystyryl)-isoxazols
DE3006809A1 (de) * 1980-02-23 1981-09-24 Basf Ag, 6700 Ludwigshafen 2-((3-amino-2-hydroxy-propoxy)-styryl)-isoxazole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
JPS5874379U (ja) * 1981-11-16 1983-05-19 富士通株式会社 電子装置
NO174506B (no) * 1984-10-30 1994-02-07 Usv Pharma Corp Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
PL3284449T3 (pl) 2011-06-10 2020-03-31 The Procter & Gamble Company Pielucha jednorazowego użytku
CN103596535B (zh) 2011-06-10 2015-11-25 宝洁公司 用于一次性吸收制品的吸收芯
JP6339010B2 (ja) 2011-06-10 2018-06-06 ザ プロクター アンド ギャンブル カンパニー 吸収性物品の吸収性構造体
EP2740449B1 (de) 2012-12-10 2019-01-23 The Procter & Gamble Company Saugfähiger artikel mit hohem anteil an absorptionsmaterial
ES2655690T3 (es) 2013-06-14 2018-02-21 The Procter & Gamble Company Artículo absorbente y canales de formación de núcleo absorbente cuando están húmedos
US9987176B2 (en) 2013-08-27 2018-06-05 The Procter & Gamble Company Absorbent articles with channels
EP3351225B1 (de) 2013-09-19 2021-12-29 The Procter & Gamble Company Absorbierende kerne mit materialfreien bereichen
PL2886092T3 (pl) 2013-12-19 2017-03-31 The Procter And Gamble Company Wkłady chłonne z obszarami tworzącymi kanały i zgrzewami osłony c

Also Published As

Publication number Publication date
DE1939809B2 (de) 1978-04-13
DK139717C (de) 1979-09-17
RO58837A (de) 1975-09-15
CH548368A (de) 1974-04-30
BG17950A3 (de) 1974-03-05
CH548981A (de) 1974-05-15
FI54912C (fi) 1979-04-10
ES382427A1 (es) 1972-11-16
CH548983A (de) 1974-05-15
CH548367A (de) 1974-04-30
ZA705411B (en) 1971-05-27
CS170537B2 (de) 1976-08-27
JPS5113149B1 (de) 1976-04-26
BG17951A3 (de) 1974-03-05
CS170534B2 (de) 1976-08-27
BG20095A3 (de) 1975-10-30
CS170538B2 (de) 1976-08-27
BG18599A3 (de) 1975-02-25
IE34634L (en) 1971-02-05
JPS5113146B1 (de) 1976-04-26
FI54912B (fi) 1978-12-29
SU450398A3 (ru) 1974-11-15
CS170533B2 (de) 1976-08-27
IL35047A (en) 1973-05-31
ES382429A1 (es) 1972-11-16
PL93130B1 (de) 1977-05-30
YU37478A (en) 1979-07-10
YU198170A (en) 1979-07-10
CS170536B2 (de) 1976-08-27
PH9520A (en) 1976-01-09
ES382426A1 (es) 1972-11-16
HU163185B (de) 1973-06-28
AT302346B (de) 1972-10-10
BE754405A (fr) 1971-02-04
ES382430A1 (es) 1972-12-01
NO135243C (de) 1977-03-09
BG17952A3 (de) 1974-03-05
BG18600A3 (de) 1975-02-25
IL35047A0 (en) 1970-10-30
JPS5113150B1 (de) 1976-04-26
KR780000113B1 (en) 1978-04-15
DE1939809C3 (de) 1979-01-11
AT302345B (de) 1972-10-10
CS170535B2 (de) 1976-08-27
JPS5113148B1 (de) 1976-04-26
DE1939809A1 (de) 1971-02-18
CH548982A (de) 1974-05-15
SU432712A3 (de) 1974-06-15
GB1307436A (en) 1973-02-21
AT303055B (de) 1972-11-10
JPS4941433B1 (de) 1974-11-08
AT301565B (de) 1972-09-11
RO57794A (de) 1975-06-15
NO135243B (de) 1976-11-29
RO57548A (de) 1975-02-15
SU428597A3 (ru) 1974-05-15
ES382425A1 (es) 1972-11-16
FR2068463A1 (de) 1971-08-27
CH548366A (de) 1974-04-30
JPS5113147B1 (de) 1976-04-26
RO58861A2 (ro) 1975-06-30
RO57793A (de) 1975-03-15
AT302344B (de) 1972-10-10
SU439965A3 (ru) 1974-08-15
SU439966A3 (ru) 1974-08-15
FR2068463B1 (de) 1974-08-30
PL78370B1 (de) 1975-06-30
DK139717B (da) 1979-04-02
ES382428A1 (es) 1972-11-16
IE34634B1 (en) 1975-07-09
NL7011590A (de) 1971-02-09

Similar Documents

Publication Publication Date Title
SE7611603L (sv) Forfarande for framstellning av mikroporos film
SE381839B (sv) Kontinuerligt forfarande for framstellning av fiberarmerat termoplastmaterial
SE382211B (sv) Forfarande for framstellning av nya beta-aryl-2-aminoalkoxi-styrener
SE414497B (sv) Forfarande for framstellning av p-karbonyloxim-fenoxialkyl-karboxamider
SE405131B (sv) Klorfattig flerstegsblekning av cellulosamassa
SE402772B (sv) Forfarande for framstellning av nya isotiocyanobensazoler
SE390736B (sv) Forfarande for framstellning av maltos
NO146189C (no) Anordning for fremstilling av kunst-kull-formlegemer
FI53897C (fi) Ljuskaensliga foereningar och foerfarande foer framstaellning av dessa
SE401186B (sv) Forfarande for framstellning av nya penicilliner
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE415758B (sv) Forfarande for framstellning av nya substituerade n-aminoalkylarylamino-imidazoliner-(2)
SE402451B (sv) Forfarande for framstellning av 14-desoxi-14-acetoximutilin
SE386902B (sv) Forfarande for framstellning av nya cefalosporiner
SE7511680L (sv) Forfarande for framstellning av furanderivat
SE388362B (sv) Kristallisationsforfarande
SE384685B (sv) Forfarande for framstellning av linkomycinderivat
FI56284B (fi) Anordning foer kontrollering av bestaemd vridningshastigheten foer loepande traod
FI53814C (fi) Foerfarande foer framstaellning av nya tuberkulostatiskt verkande alfa-aminoxikarbonyl-hydroxamsyra-derivat
SE383631B (sv) Forfarande for framstellning av nya 1-fenoxi-2-hydroxid-3-hydroxialkylaminopropaner
SE385587B (sv) Forfarande for framstellning av tvakomponentkomplex
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE394668B (sv) Forfarande for framstellning av 2-etylhexan-1-al
NO137050C (no) Fremgangsm}te til fremstilling av butyrofenonderivater
SE387106B (sv) Forfarande for framstellning av alkanoner med 3-4 kolatomer ur olefiner